TY - JOUR
T1 - Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
AU - Andreotti, Felicita
AU - Rocca, Bianca
AU - Husted, S
AU - Ajjan, Ra
AU - Ten Berg, J
AU - Cattaneo, M
AU - Collet, J
AU - De Caterina, R
AU - Fox, Kaa
AU - Halvorsen, S
AU - Huber, K
AU - Hylek, Em
AU - Lip, Gyh
AU - Montalescot, G
AU - Morais, J
AU - Patrono, Carlo
AU - Verheugt, Fwa
AU - Wallentin, L
AU - Weiss, Tw
AU - Storey, Rf
PY - 2015
Y1 - 2015
N2 - Contemporary medicine is shifting towards person rather than\r\ndisease-oriented care.1With increasing life expectancy and the ageing\r\nof baby boomers, the proportion over 60 years is growing faster\r\nthan the overall population, with worldwide estimates reaching\r\n2 billion by 2050 (http://www.un.org/esa/population/publications/\r\nworldageing19502050).2 In parallel, acute coronary syndromes\r\n(ACS) and atrial fibrillation (AF)—the most frequent indications\r\nfor dual platelet inhibition or anticoagulation—occur mostly in older\r\npatients.2 – 6 There is general agreement that people ≥75 years\r\ncan be defined ‘elderly’; however, cutoffs as low as 65 years have\r\nbeen applied to important clinical datasets and risk scores.3,7 – 10
AB - Contemporary medicine is shifting towards person rather than\r\ndisease-oriented care.1With increasing life expectancy and the ageing\r\nof baby boomers, the proportion over 60 years is growing faster\r\nthan the overall population, with worldwide estimates reaching\r\n2 billion by 2050 (http://www.un.org/esa/population/publications/\r\nworldageing19502050).2 In parallel, acute coronary syndromes\r\n(ACS) and atrial fibrillation (AF)—the most frequent indications\r\nfor dual platelet inhibition or anticoagulation—occur mostly in older\r\npatients.2 – 6 There is general agreement that people ≥75 years\r\ncan be defined ‘elderly’; however, cutoffs as low as 65 years have\r\nbeen applied to important clinical datasets and risk scores.3,7 – 10
KW - antithrombotic therapy
KW - elderly
KW - antithrombotic therapy
KW - elderly
UR - https://publicatt.unicatt.it/handle/10807/68473
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84949915221&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84949915221&origin=inward
U2 - 10.1093/eurheartj/ehv304
DO - 10.1093/eurheartj/ehv304
M3 - Article
SN - 0195-668X
VL - 36
SP - 3238
EP - 3249
JO - European Heart Journal
JF - European Heart Journal
IS - 46
ER -
